Corticosteroid management of feline IBD requires careful dosing and monitoring to control inflammation while minimising steroid side effects.
Corticosteroid management of IBD involves a welfare trade-off between disease control and steroid side effects. High-dose steroids cause significant physiological changes including polydipsia, polyphagia, and muscle wasting that themselves reduce quality of life. Finding the minimum effective dose through careful tapering while monitoring disease response provides the best welfare outcome - adequate disease control at minimum side effect burden.